Product information and disease descriptionPlace of product in therapyDisease description
Pathophysiology
7 evidence topics · 6 sources
IL-23/IL-17 axis as the central immune pathway
“Over the last two decades, research has unequivocally shown that psoriasis represents a bona fide T-cell mediated disease primarily driven by pathogenic T-cells that produce high levels of IL-17 in response to IL-23.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Psoriatic disease is, therefore, best understood as a patterned response to chronic activation of the IL-23/T17 pathway.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
IL-17 and IL-23 as key drivers identified by immunological and genetic studies
Interplay of T cells, dendritic cells, and keratinocytes
“This suggests a complex interplay between T cells, dendritic cells and keratinocytes as the likely underlying the pathophysiology of psoriasis, with the IL-23/Th17 axis being the central driver of immune activation, chronic inflammation and keratinocyte proliferation.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Keratinocyte responses to IL-17: epidermal hyperplasia and leukocyte recruitment
“Epidermal hyperplasia, a hallmark of psoriatic plaques, is associated with STAT3 activation and indirectly regulated by IL-17 through the induction of IL-19 and/or IL-36 by keratinocytes.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“IL-17 induces keratinocytes to synthesize and release CXCL1, CXCL2, CXCL3, CXCL5, and CXCL8 (i.e. IL-8), which leads to the recruitment of neutrophils and macrophages.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
TYK2 signaling downstream of IL-12, IL-23, and type I interferon receptors
“Plaque psoriasis is a common, chronic, systemic, immune-mediated inflammatory disease. The Janus kinase-signal transducer and activator of transcription pathway plays a major role in intracellular cytokine signaling in inflammatory processes involved in psoriasis.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Tyrosine kinase 2 (TYK2) is a member of the JAK family of kinases and regulates signaling and functional responses downstream of the interleukin 12, interleukin 23, and type I interferon receptors.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
TYK2 partner kinases and STAT proteins by cytokine
“TYK2 pairs with JAK2 and engages mainly STAT4 to mediate signal transduction of IL-12.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The TYK2/JAK2 heterodimer, acting through STAT1, STAT3, and STAT4, is likewise required for IL-23 signalling, which regulates the differentiation and survival of Th17 cells.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Loss-of-function TYK2 variant P1104A: protection against psoriasis and other autoimmune diseases
“Rs34536443 leads to the substitution of a highly conserved proline residue with an alanine at position 1104 (P1104A) in the kinase domain of the TYK2 protein” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“In contrast, the rs34536443 minor allele is protective across all of the diseases tested, and surprisingly, its dosage effect shows a previously unrecognized significant departure from additivity” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“This arises from minor allele homozygosity at the rs34536443 SNP, which drives a near complete loss of TYK2 function and consequently impairs type I IFN, IL-12 and IL-23 signaling.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote